MIOSTAT

This brand name is authorized in Canada, Ecuador, Estonia, France, Hong Kong, Netherlands, New Zealand, Poland, Singapore, Turkey, United States

Active ingredients

The drug MIOSTAT contains one active pharmaceutical ingredient (API):

1 Carbachol UNII 8Y164V895Y - CARBACHOL

Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure (IOP). Read about Carbachol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MIOSTAT Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EB02	Carbachol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00042544
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 16.108-2-04-02
Country: EE	Ravimiamet	Identifier(s): 1111789, 1730348
Country: FR	Base de données publique des médicaments	Identifier(s): 67713498
Country: HK	Department of Health Drug Office	Identifier(s): 24136
Country: NL	Z-Index G-Standaard	Identifier(s): 13930656
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 27839
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2405
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100044030
Country: SG	Health Sciences Authority	Identifier(s): 04572P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699760610189, 8699760610196
Country: US	FDA, National Drug Code	Identifier(s): 0065-0023